...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Revista de Saúde Pública >Direct treatment costs of HIV/AIDS in Portugal
【24h】

Direct treatment costs of HIV/AIDS in Portugal

机译：葡萄牙艾滋病毒/艾滋病的直接治疗费用

获取原文
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

OBJECTIVE To analyze the direct medical costs of HIV/AIDS in Portugal from the perspective of the National Health Service. METHODS A retrospective analysis of medical records was conducted for 150 patients from five specialized centers in Portugal in 2008. Data on utilization of medical resources during 12 months and patients’ characteristics were collected. A unit cost was applied to each care component using official sources and accounting data from National Health Service hospitals. RESULTS The average cost of treatment was 14,277 €/patient/year. The main cost-driver was antiretroviral treatment (€ 9,598), followed by hospitalization costs (€ 1,323). Treatment costs increased with the severity of disease from € 11,901 ( 500 CD4 cells/µl) to € 23,351 (CD4 count ≤ 50 cells/ µl). Cost progression was mainly due to the increase in hospitalization costs, while antiretroviral treatment costs remained stable over disease stages. CONCLUSIONS The high burden related to antiretroviral treatment is counterbalanced by relatively low hospitalization costs, which, however, increase with severity of disease. The relatively modest progression of total costs highlights that alternative public health strategies that do not affect transmission of disease may only have a limited impact on expenditure, since treatment costs are largely dominated by constant antiretroviral treatment costs.
机译：目的从国家卫生局的角度分析葡萄牙艾滋病毒/艾滋病的直接医疗费用。方法2008年对葡萄牙五个专门中心的150名患者的病历进行了回顾性分析。收集了12个月内医疗资源的利用情况和患者特征的数据。使用官方数据来源和国家卫生局（National Health Service）医院的会计数据将单价应用于每个护理组件。结果平均治疗费用为14,277€/患者/年。主要的成本驱动因素是抗逆转录病毒治疗（9,598欧元），其次是住院费用（1,323欧元）。随着疾病的严重程度，治疗费用从11,901欧元（> 500个CD4细胞/微升）增加到23,351欧元（CD4计数≤50个细胞/微升）。费用增长主要是由于住院费用的增加，而抗逆转录病毒治疗费用在疾病阶段仍保持稳定。结论相对较低的住院费用抵消了与抗逆转录病毒治疗相关的高负担，但是住院费用却随着疾病的严重程度而增加。总费用的相对适度增长表明，不影响疾病传播的替代性公共卫生策略可能只会对支出产生有限的影响，因为治疗费用主要由恒定的抗逆转录病毒治疗费用决定。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号